Cutler Group LP 23and Me Holding Co. Call Options Transaction History

Cutler Group LP

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2023 May 01, 2023	SELL	$2.05 - $2.87 $112,954 - $158,137	-55,100 Reduced 98.92%	600 $0
Q4 2022 Feb 07, 2023	SELL	$2.06 - $3.47 $4,738 - $7,981	-2,300 Reduced 3.97%	55,700 $1,000
Q3 2022 Oct 25, 2022	SELL	$2.6 - $5.12 $105,040 - $206,848	-40,400 Reduced 41.06%	58,000 $2,000
Q2 2022 Aug 04, 2022	BUY	$2.19 - $3.98 $24,966 - $45,372	11,400 Added 13.1%	98,400 $3,000
Q1 2022 Apr 14, 2022	SELL	$3.28 - $7.12 $70,192 - $152,368	-21,400 Reduced 19.74%	87,000 $11,000
Q4 2021 Jan 18, 2022	SELL	$6.55 - $13.25 $740,150 - $1.5 Million	-113,000 Reduced 51.04%	108,400 $36,000
Q3 2021 Oct 26, 2021	BUY	$7.29 - $11.0 $225,990 - $341,000	31,000 Added 16.28%	221,400 $84,000
Q2 2021 Jul 19, 2021	BUY	$9.87 - $13.32 $1.88 Million - $2.54 Million	190,400 New	190,400 $139,000

116

82.5M

404K

292K

Ticker ME
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 259,768,000
Market Cap $795M
Description
23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of pa...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.